Stimvia completes enrollment in study of neurostim for Parkinson’s

The Uris system. [Image courtesy of Stimvia]Stimvia announced today that it completed enrollment in a study of neuromodulation for treating Parkinson’s disease and essential tremor.

The study evaluates the Czech Republic-based company’s Uris device, which uses peroneal neuromodulation (eTNM) for deep brain stimulation. The Uris system previously demonstrated high effectiveness in treating overactive bladder.

Uris, a non-invasive system, utilizes active closed-loop biofeedback. Its design aims to provide afferent stimulation of higher levels of the central nervous system through peroneal eTNM. The system stimulates the common peroneal nerve on the lower limbs of patients for home-based treatment. Uris delivers stimulation in a 30-minute session performed once daily for 12 weeks.

The study of Uris assesses the positive impact on the symptoms of patients with Parkinson’s or essential tremor disorders. Stimvia said it also evaluates the influe…

Read more
  • 0